IceCure Medical/ICCM

$1.32

1.53%
-
1D1W1MYTD1YMAX

About IceCure Medical

Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Ticker
ICCM
Sector
Healthcare
Trading on
NASDAQ
Industry
Medical Equipment & Supplies
CEO
Eyal Shamir
Employees
65
Headquarters
Caesarea, Israel

IceCure Medical Metrics

BasicAdvanced
$60.36M
Market cap
-
P/E ratio
-$0.42
EPS
2.90
Beta
-
Dividend rate

What the Analysts think about IceCure Medical

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
133.33% upside
High $4.41
Low $1.90
$1.32
Current price
$3.08
Average price target

IceCure Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-528.57% profit margin
QuarterlyAnnual
Q1 23
QoQ growth
Revenue
$700K
-22.22%
Net income
$-3.7M
-5.13%
Profit margin
-528.57%
21.98%

IceCure Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.33%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.11
-$0.08
-$0.08
-$0.09
-
Expected
-$0.10
-$0.09
-$0.09
-$0.09
-$0.07
Surprise
6.45%
-14.29%
-7.69%
-3.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell IceCure Medical stock

Buy or sell IceCure Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing